Harrow Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2024 | 1 | $0.13 | $0.13 | $0.13 |
| Q1 2025 | 1 | $0.03 | $0.04 | $0.04 |
| Q2 2025 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2025 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2025 | 1 | $0.23 | $0.23 | $0.23 |
| Q1 2026 | 1 | $0.27 | $0.27 | $0.27 |
| Q2 2026 | 1 | $0.30 | $0.30 | $0.30 |
| Q3 2026 | 1 | $0.34 | $0.34 | $0.34 |
| Q4 2026 | 1 | $0.60 | $0.60 | $0.60 |
Harrow Health, Inc. Earnings Date And Information
Harrow Health, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.25 by $0.12. The company had revenue of 49.26 M for the quarter and had revenue of 130.19 M for the year. Harrow Health, Inc. has generated $-1 earnings per share over the last year ($-0.75 diluted earnings per share) and currently has a price-to-earnings ratio of -45.85. Harrow Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Harrow Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.12 | $52.80 M | $49.26 M | ||
| 08/07/2024 | Q2 2024 | -$0.25 | -$0.18 | 0.07 | $42.51 M | $48.94 M |
| 05/13/2024 | Q1 2024 | -$0.25 | -$0.38 | -0.13 | $34.59 M | |
| 03/19/2024 | Q4 2023 | -$0.04 | -$0.26 | -0.22 | $36.36 M | |
| 11/13/2023 | Q3 2023 | -$0.02 | -$0.13 | -0.11 | $37.58 M | $34.27 M |
| 08/09/2023 | Q2 2023 | -$0.01 | -$0.14 | -0.13 | $31.04 M | $33.47 M |
| 05/11/2023 | Q1 2023 | -$0.06 | -$0.22 | -0.16 | $26.10 M | |
| 03/23/2023 | Q4 2022 | -$0.15 | $0.04 | 0.19 | $20.33 M | |
| 11/14/2022 | Q3 2022 | -$0.00 | -$0.24 | -0.24 | $23.14 M | $22.82 M |
| 08/09/2022 | Q2 2022 | -$0.00 | -$0.23 | -0.23 | $22.07 M | $23.32 M |
| 05/05/2022 | Q1 2022 | $0.01 | -$0.08 | -0.1 | $22.12 M | |
| 03/10/2022 | Q4 2021 | $0.08 | -$0.27 | -0.35 | $20.19 M | |
| 11/09/2021 | Q3 2021 | -$0.00 | -$0.31 | -0.31 | $17.44 M | $18.71 M |
| 08/10/2021 | Q2 2021 | -$0.13 | -$0.09 | 0.04 | $15.71 M | $18.13 M |
| 05/11/2021 | Q1 2021 | $0.00 | $0.01 | 0.01 | $15.44 M | |
| 03/08/2021 | Q4 2020 | $0.04 | $0.04 | 0 | $14.60 M | |
| 11/09/2020 | Q3 2020 | $0.17 | $0.33 | 0.16 | $9.34 M | $14.40 M |
| 08/10/2020 | Q2 2020 | -$0.05 | -$0.01 | 0.04 | $5.70 M | $8.06 M |
| 05/11/2020 | Q1 2020 | -$0.50 | -$0.50 | 0 | $11.82 M | |
| 03/13/2020 | Q4 2019 | $0.13 | $0.29 | 0.16 | $12.60 M |
Harrow Health, Inc. Earnings: Frequently Asked Questions
-
When is Harrow Health, Inc.'s earnings date?
Harrow Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
Did Harrow Health, Inc. beat their earnings estimates last quarter?
In the previous quarter, Harrow Health, Inc. (:HROW) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.25 by $0.12.
-
How can I listen to Harrow Health, Inc.'s earnings conference call?
The conference call for Harrow Health, Inc.'s latest earnings report can be listened to online.
-
How can I read Harrow Health, Inc.'s conference call transcript?
The conference call transcript for Harrow Health, Inc.'s latest earnings report can be read online.
-
How much revenue does Harrow Health, Inc. generate each year?
Harrow Health, Inc. (:HROW) has a recorded annual revenue of $130.19 M.
-
How much profit does Harrow Health, Inc. generate each year?
Harrow Health, Inc. (:HROW) has a recorded net income of $130.19 M. Harrow Health, Inc. has generated $-0.75 earnings per share over the last four quarters.
-
What is Harrow Health, Inc.'s price-to-earnings ratio?
Harrow Health, Inc. (:HROW) has a price-to-earnings ratio of -45.85 and price/earnings-to-growth ratio is -43.56.
